387 related articles for article (PubMed ID: 27111902)
1. Immune Checkpoint Therapy in Non-Small Cell Lung Cancer.
Marrone KA; Brahmer JR
Cancer J; 2016; 22(2):81-91. PubMed ID: 27111902
[TBL] [Abstract][Full Text] [Related]
2. Immunotherapy with checkpoint inhibitors for lung cancer: novel agents, biomarkers and paradigms.
Monteiro ID; Califano R; Mountzios G; de Mello RA
Future Oncol; 2016 Feb; 12(4):551-64. PubMed ID: 26776915
[TBL] [Abstract][Full Text] [Related]
3. Immune Checkpoint Therapies in Prostate Cancer.
Goswami S; Aparicio A; Subudhi SK
Cancer J; 2016; 22(2):117-20. PubMed ID: 27111907
[TBL] [Abstract][Full Text] [Related]
4. Immune Checkpoint Therapy in Melanoma.
Callahan MK
Cancer J; 2016; 22(2):73-80. PubMed ID: 27111901
[TBL] [Abstract][Full Text] [Related]
5. Endocrinopathies induced by immune-checkpoint inhibitors in advanced non-small cell lung cancer.
Rossi E; Sgambato A; De Chiara G; Casaluce F; Losanno T; Sacco PC; Santabarbara G; Gridelli C
Expert Rev Clin Pharmacol; 2016; 9(3):419-28. PubMed ID: 26681547
[TBL] [Abstract][Full Text] [Related]
6. Immune Checkpoint Therapy in Head and Neck Cancers.
Msaouel P; Massarelli E
Cancer J; 2016; 22(2):108-16. PubMed ID: 27111906
[TBL] [Abstract][Full Text] [Related]
7. The State of Immune Checkpoint Inhibition in Urothelial Carcinoma: Current Evidence and Future Areas of Exploration.
Campbell MT; Siefker-Radtke AO; Gao J
Cancer J; 2016; 22(2):96-100. PubMed ID: 27111904
[TBL] [Abstract][Full Text] [Related]
8. Current Perspectives in Immunotherapy for Non-Small Cell Lung Cancer.
Garon EB
Semin Oncol; 2015 Oct; 42 Suppl 2():S11-8. PubMed ID: 26477470
[TBL] [Abstract][Full Text] [Related]
9. Checkpoint inhibitors in breast cancer: hype or promise?
McArthur HL
Clin Adv Hematol Oncol; 2016 Jun; 14(6):392-5. PubMed ID: 27379806
[No Abstract] [Full Text] [Related]
10. Immunotherapy for the treatment of breast cancer: checkpoint blockade, cancer vaccines, and future directions in combination immunotherapy.
McArthur HL; Page DB
Clin Adv Hematol Oncol; 2016 Nov; 14(11):922-933. PubMed ID: 27930644
[TBL] [Abstract][Full Text] [Related]
11. Immune Checkpoint Inhibitor Therapy: What Line of Therapy and How to Choose?
Ramamurthy C; Godwin JL; Borghaei H
Curr Treat Options Oncol; 2017 Jun; 18(6):33. PubMed ID: 28534248
[TBL] [Abstract][Full Text] [Related]
12. [Non-Small Cell Lung Cancer - from Immunobiology to Immunotherapy].
Bílek O; Bohovicová L; Demlová R; Poprach A; Lakomý R; Zdražilová-Dubská L
Klin Onkol; 2016; 29 Suppl 4(Suppl 4):78-87. PubMed ID: 27846725
[TBL] [Abstract][Full Text] [Related]
13. Emerging immunotherapies in the treatment of non-small cell lung cancer (NSCLC): the role of immune checkpoint inhibitors.
Langer CJ
Am J Clin Oncol; 2015 Aug; 38(4):422-30. PubMed ID: 24685885
[TBL] [Abstract][Full Text] [Related]
14. Incorporating immune-checkpoint inhibitors into systemic therapy of NSCLC.
Champiat S; Ileana E; Giaccone G; Besse B; Mountzios G; Eggermont A; Soria JC
J Thorac Oncol; 2014 Feb; 9(2):144-53. PubMed ID: 24419410
[TBL] [Abstract][Full Text] [Related]
15. Immune Checkpoint Inhibitors in the Treatment of Gynecologic Malignancies.
Ring KL; Pakish J; Jazaeri AA
Cancer J; 2016; 22(2):101-7. PubMed ID: 27111905
[TBL] [Abstract][Full Text] [Related]
16. Best practice in the treatment of advanced squamous cell lung cancer.
Ang YL; Tan HL; Soo RA
Ther Adv Respir Dis; 2015 Oct; 9(5):224-35. PubMed ID: 25902866
[TBL] [Abstract][Full Text] [Related]
17. Non-Small Cell Lung Cancer, PD-L1, and the Pathologist.
Kerr KM; Nicolson MC
Arch Pathol Lab Med; 2016 Mar; 140(3):249-54. PubMed ID: 26927720
[TBL] [Abstract][Full Text] [Related]
18. Is minimal residual disease a convincing tool to determine the treatment duration of immune checkpoint inhibitors?
El Rassy E; Assi T; Kattan J
Future Oncol; 2017 Feb; 13(5):381-383. PubMed ID: 27884060
[No Abstract] [Full Text] [Related]
19. Immune Checkpoint Inhibitors: New Insights and Current Place in Cancer Therapy.
La-Beck NM; Jean GW; Huynh C; Alzghari SK; Lowe DB
Pharmacotherapy; 2015 Oct; 35(10):963-76. PubMed ID: 26497482
[TBL] [Abstract][Full Text] [Related]
20. Checkpoint inhibitors in the treatment of brain metastases of non-small-cell lung cancer and melanoma.
Kourie HR; Kanaan H; Awada G; Awada AH
Future Oncol; 2017 May; 13(12):1097-1103. PubMed ID: 28326837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]